Tag Page PharmaWatch

Vaccine Pause After Scary Side Effects

French health officials just hit pause on Valneva’s new chikungunya vaccine for people 65+ after three hospitalizations and one death on La Reunion island. The shot’s still good for younger adults, but they’re investigating if it’s risky for seniors—especially those with health issues. The same vaccine’s under review in the US too. Wild how fast things can change with new meds! #VaccineNews #HealthUpdate #Chikungunya #Valneva #PharmaWatch #Health